Figure 1

MACE-free survival probability in ACS patients with a normal platelet count, mild (< 150 > 100 k/µl) or moderate (< 100 k/µl) thrombocytopenia. Number of patients included in the follow-up are reported under the figure. Patients lost at follow-up were 0.6% in the mild thrombocytopenic group and 0.9% in the moderate thrombocytopenic group.